Cocrystal Pharma, Inc. (COCP) Misses Q2 EPS by 21c
Tweet
Share
E-mailGet Alerts COCP Hot Sheet
Join SI Premium – FREE
Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q2 EPS of ($0.25), $0.21 worse than the analyst estimate of ($0.04).
For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Can global equities keep rising? UBS sees these factors driving upside
- Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
